A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4(+)CD25(+) cells and TGF-β

Documenti analoghi

• Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action
  di: Sharabi, Amir, et al.
  Pubblicazione: (2007)
• The Tolerogenic Peptide, hCDR1, Down-Regulates the Expression of Interferon-α in Murine and Human Systemic Lupus Erythematosus
  di: Sthoeger, Zev, et al.
  Pubblicazione: (2013)
• Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients
  di: MAUERMANN, N, et al.
  Pubblicazione: (2004)
• In Vivo Dynamical Interactions between CD4 Tregs, CD8 Tregs and CD4(+)CD25(−) Cells in Mice
  di: Arazi, Arnon, et al.
  Pubblicazione: (2009)
• The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus
  di: Eilat, Eran, et al.
  Pubblicazione: (2001)